GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 81 filers reported holding GALENA BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $12,000 | -7.7% | 35,472 | +26.5% | 0.00% | – |
| Q2 2016 | $13,000 | -64.9% | 28,045 | -0.1% | 0.00% | – |
| Q1 2016 | $37,000 | -36.2% | 28,079 | -30.5% | 0.00% | – |
| Q4 2015 | $58,000 | -25.6% | 40,390 | -19.2% | 0.00% | – |
| Q3 2015 | $78,000 | +5.4% | 49,987 | +12.9% | 0.00% | – |
| Q2 2015 | $74,000 | +516.7% | 44,288 | +351.0% | 0.00% | – |
| Q1 2015 | $12,000 | +71.4% | 9,819 | +93.6% | 0.00% | – |
| Q4 2014 | $7,000 | -72.0% | 5,073 | -60.7% | 0.00% | – |
| Q3 2014 | $25,000 | -84.9% | 12,922 | -76.4% | 0.00% | – |
| Q2 2014 | $166,000 | -83.0% | 54,671 | -86.3% | 0.00% | -100.0% |
| Q1 2014 | $979,000 | +888.9% | 399,577 | +1887.2% | 0.00% | – |
| Q4 2013 | $99,000 | -63.1% | 20,108 | -83.0% | 0.00% | – |
| Q3 2013 | $268,000 | – | 117,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harbour Capital Advisors, LLC | 114,350 | $236,000 | 0.20% |
| Thomasville National Bank | 95,000 | $195,000 | 0.08% |
| SMITH ASSET MANAGEMENT GROUP LP | 552,160 | $1,137,000 | 0.04% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $243,000 | 0.03% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $61,000 | 0.03% |
| Alyeska Investment Group, L.P. | 530,000 | $1,092,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 282,704 | $582,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $41,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $31,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 539,031 | $1,110,000 | 0.02% |